OP Asset Management Ltd Takes $7.25 Million Position in Cigna Group $CI

OP Asset Management Ltd bought a new stake in shares of Cigna Group (NYSE:CI) during the first quarter, HoldingsChannel.com reports. The institutional investor bought 27,193 shares of the health services provider’s stock, valued at approximately $7,254,000.

Several other hedge funds also recently bought and sold shares of the company. Banco Bilbao Vizcaya Argentaria S.A. lifted its holdings in Cigna Group by 13.5% in the 3rd quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 34,114 shares of the health services provider’s stock worth $9,839,000 after purchasing an additional 4,066 shares in the last quarter. Distillate Capital Partners LLC grew its holdings in Cigna Group by 19.1% during the 3rd quarter. Distillate Capital Partners LLC now owns 108,676 shares of the health services provider’s stock valued at $31,338,000 after buying an additional 17,442 shares in the last quarter. Cooperman Leon G raised its position in shares of Cigna Group by 53.3% during the third quarter. Cooperman Leon G now owns 325,000 shares of the health services provider’s stock valued at $93,681,000 after buying an additional 113,000 shares during the last quarter. Schroder Investment Management Group raised its position in shares of Cigna Group by 53.0% during the third quarter. Schroder Investment Management Group now owns 190,710 shares of the health services provider’s stock valued at $54,972,000 after buying an additional 66,090 shares during the last quarter. Finally, apricus wealth LLC lifted its holdings in shares of Cigna Group by 715.9% in the fourth quarter. apricus wealth LLC now owns 9,505 shares of the health services provider’s stock worth $2,616,000 after buying an additional 8,340 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.

Insider Activity

In related news, CEO David Cordani sold 201,878 shares of the stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the transaction, the chief executive officer owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the transaction, the chief accounting officer owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This represents a 27.52% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.60% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on CI. Sanford C. Bernstein upped their target price on shares of Cigna Group from $358.00 to $371.00 and gave the stock an “outperform” rating in a research report on Tuesday, May 5th. The Goldman Sachs Group boosted their price target on shares of Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. Barclays downgraded shares of Cigna Group from an “overweight” rating to an “equal weight” rating and dropped their price objective for the company from $310.00 to $304.00 in a report on Tuesday, May 26th. Deutsche Bank Aktiengesellschaft lowered Cigna Group from a “buy” rating to a “hold” rating and cut their price objective for the company from $303.00 to $302.00 in a research report on Wednesday, May 20th. Finally, Robert W. Baird set a $337.00 target price on Cigna Group in a report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $338.30.

Cigna Group Trading Up 0.9%

CI stock opened at $281.92 on Friday. The firm has a fifty day moving average price of $284.38 and a 200 day moving average price of $278.71. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $338.89. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. The firm has a market cap of $74.58 billion, a PE ratio of 11.95, a price-to-earnings-growth ratio of 1.08 and a beta of 0.28.

Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The company had revenue of $68.52 billion for the quarter, compared to the consensus estimate of $66.29 billion. During the same quarter in the prior year, the firm earned $6.74 earnings per share. Cigna Group’s revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Sell-side analysts anticipate that Cigna Group will post 30.39 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th were given a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date was Thursday, June 4th. Cigna Group’s dividend payout ratio is currently 26.45%.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.